Section 301 Petition on Chinese Fentanyl Actions Call for Tariffs, Other Retaliatory Responses

Last week, a group focused on the harms of fentanyl filed a Section 301 petition with the Office of the United States Trade Representative (USTR), arguing that China's "acts, policies, and practices" in this area harm U.S. commerce, and requesting a range of tariffs and other remedies as a response.